| Year |
Citation |
Score |
| 2020 |
Chen YY, Lo CF, Chiu TY, Hsu CY, Yeh TK, Chen CP, Huang CL, Huang CY, Wang MH, Huang YC, Ho HH, Chao YS, Shih JC, Tsou LK, Chen CT. BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy. Translational Oncology. 14: 100897. PMID 33069101 DOI: 10.1016/j.tranon.2020.100897 |
0.315 |
|
| 2020 |
Chen YJ, Tsai CY, Cheng YM, Nieh SW, Yeh TK, Chen CP, Wang MH, Chou LH, Chiu TY, Liu L, Ho C, Chen CT, Liu TW. Impacts of Intralipid on Nanodrug Abraxane Therapy and on the Innate Immune System. Scientific Reports. 10: 2838. PMID 32071352 DOI: 10.1038/S41598-020-59813-7 |
0.336 |
|
| 2011 |
Lu Z, Yeh TK, Wang J, Chen L, Lyness G, Xin Y, Wientjes MG, Bergdall V, Couto G, Alvarez-Berger F, Kosarek CE, Au JL. Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy. The Journal of Urology. 185: 1478-83. PMID 21334664 DOI: 10.1016/J.Juro.2010.11.091 |
0.66 |
|
| 2009 |
Au JL, Lu Z, Yeh T, Lyness G, Chen L, Xin Y, Miller A, Ferry M, McKeegan J, Wientjes MG, Couto G, Alvarez-Berger F, Eosarek CE. RAPID RELEASE PACLITAXEL NANOPARTICLES FOR INTRAVESICAL THERAPY IN DOGS WITH SPONTANEOUS BLADDER CANCER The Journal of Urology. 181: 635. DOI: 10.1016/S0022-5347(09)61784-5 |
0.686 |
|
| 2008 |
Villalona-Calero MA, Otterson GA, Wientjes MG, Weber F, Bekaii-Saab T, Young D, Murgo AJ, Jensen R, Yeh TK, Wei Y, Zhang Y, Eng C, Grever M, Au JL. Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 19: 1903-9. PMID 18632723 DOI: 10.1093/Annonc/Mdn412 |
0.695 |
|
| 2007 |
Tsai M, Lu Z, Wang J, Yeh TK, Wientjes MG, Au JL. Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel. Pharmaceutical Research. 24: 1691-701. PMID 17447121 DOI: 10.1007/S11095-007-9298-0 |
0.75 |
|
| 2007 |
Au JLS, Olencki T, Wientjes MG, Otterson G, Saab T, Grainger A, Yeh T, Jensen R, Young D, Calero Mv. P2-230: A Phase I Study of Nontoxic Suramin As A Chemosensitizer In Pretreated/Refractory Non-Small Cell Lung Cancer (NSCLC) Patients Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283938.40281.52 |
0.392 |
|
| 2006 |
Chen D, Song SH, Wientjes MG, Yeh TK, Zhao L, Villalona-Calero M, Otterson GA, Jensen R, Grever M, Murgo AJ, Au JL. Nontoxic suramin as a chemosensitizer in patients: dosing nomogram development. Pharmaceutical Research. 23: 1265-74. PMID 16715360 DOI: 10.1007/s11095-006-0165-1 |
0.529 |
|
| 2005 |
Olencki T, Wientjes G, Otterson G, Saab T, Grainger A, Yeh T, Jensen R, Young D, Au J, Villalona Calero M. Modulation of chemotherapy resistance with low dose suramin in refractory non-small cell lung cancer (NSCLC) patients: A phase I study of sequential non-cross resistant chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2104. PMID 27943974 DOI: 10.1200/Jco.2005.23.16_Suppl.2104 |
0.61 |
|
| 2005 |
Yeh TK, Lu Z, Wientjes MG, Au JL. Formulating paclitaxel in nanoparticles alters its disposition. Pharmaceutical Research. 22: 867-74. PMID 15948030 DOI: 10.1007/s11095-005-4581-4 |
0.632 |
|
| 2004 |
Lu Z, Yeh TK, Tsai M, Au JL, Wientjes MG. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7677-84. PMID 15570001 DOI: 10.1158/1078-0432.Ccr-04-1443 |
0.769 |
|
| 2003 |
Villalona-Calero MA, Wientjes MG, Otterson GA, Kanter S, Young D, Murgo AJ, Fischer B, DeHoff C, Chen D, Yeh TK, Song S, Grever M, Au JL. Phase I study of low-dose suramin as a chemosensitizer in patients with advanced non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 3303-11. PMID 12960116 |
0.621 |
|
| 2003 |
Villalona-Calero MA, Otterson G, Wientjes G, Murgo A, Jensen R, Yeh T, Chen D, Song S, Grever M, Au J. P-229 Phase II evaluation of low dose suramin as a modulator of paclitaxel/carboplatin (P/C) in non-small cell lung cancer (NSCLC) patients Lung Cancer. 41. DOI: 10.1016/S0169-5002(03)92198-2 |
0.624 |
|
| 1996 |
Yeh TK, Kang HJ, Wientjes MG, Au JL. Pharmacokinetic interaction between intravenous 2',3'-dideoxyinosine and pentamidine in rats. Pharmaceutical Research. 13: 628-32. PMID 8710758 DOI: 10.1023/A:1016018726327 |
0.542 |
|
| 1993 |
Yeh TK, Dalton JT, Au JL. High-performance liquid chromatographic determination of pentamidine in plasma. Journal of Chromatography. 622: 255-61. PMID 8150874 DOI: 10.1016/0378-4347(93)80274-8 |
0.551 |
|
| Show low-probability matches. |